Dyne Therapeutics is a clinical-stage biotechnology company working to deliver life-transforming therapies for patients with genetically driven neuromuscular diseases. By leveraging their proprietary FORCE platform, they aim to overcome the limitations of current approaches by targeting the root cause of conditions such as Duchenne muscular dystrophy, myotonic dystrophy type 1, and facioscapulohumeral muscular dystrophy.
Working at Dyne means joining a mission-driven team dedicated to precision medicine and scientific excellence. The company offers a vibrant, fast-paced environment where employees have the opportunity to make a tangible impact on patients' lives while advancing the frontiers of modern therapeutic development.